Microphysiological Drug-Testing Platform For Identifying Responses To Prodrug Treatment In Primary Leukemia
F. Gokce, A. Kaestli, C. Lohasz, M. de Geus, H. M. Kaltenbach, K. Renggli, B. Bornhauser, A. Hierlemann, M. M. Modena
The paper develops a microphysiological platform to test prodrug responses in leukemia samples, identifying sample-specific sensitivities to ifosfamide.
bioRxiv · Apr 6, 2022Bioengineering